Technically the stock has a price volume breakout. With that, the stock crossed the previous swing high.
The stock has gained about 25% in the last 2 weeks. With good volume being bought. The stock is currently above all moving averages. Also, the stock looks bullish in all the short, medium and long term.
14-period daily RSI (67.08) is in bullish zone. Which is indicative of good, strong financial position of the stock.
The MACD histogram is bullish and indicates that the stock may rise further. OBV is peaking and trading volume is increasing, which is a sign of that.
The company’s stock rose 5% in after-hours trading on Tuesday.—Symbol
In short the stock looks strong in the medium term and the stock is expected to perform well in the coming days.
Shares of HIKAL traded at Rs 427 on Tuesday. As a result, investors can keep an eye on the stock.
Hikal is associated with research and development in the international pharmaceutical field. The company provides services to animal health, biotech, crop protection and specialty chemicals companies.
This article is powered by ‘Dalal Street Investment Journal’, India’s No 1 investment magazine. To be regularly updated about winning stocks and recommendations do join by clicking here.
Disclaimer : This above is third party content and TIL hereby disclaims any and all warranties, express or implied, relating to the same. TIL does not guarantee, vouch for or endorse any of the above content or its accuracy nor is responsible for it in any manner whatsoever. The content does not constitute any investment advice or solicitation of any kind. Users are advised to check with certified experts before taking any investment decision and take all steps necessary to ascertain that any information and content provided is correct, updated and verified.